Reply

Amit G. Singal; Neehar D. Parikh; Caitlin C. Murphy

doi:10.1053/j.gastro.2020.02.024

Reply

Amit G. Singal, Neehar D. Parikh, Caitlin C. Murphy

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1844
Number of pages	1
Journal	Gastroenterology
Volume	158
Issue number	6
DOIs	https://doi.org/10.1053/j.gastro.2020.02.024
State	Published - May 2020

ASJC Scopus subject areas

Hepatology
Gastroenterology

Access to Document

10.1053/j.gastro.2020.02.024

Cite this

@article{2486a336d77a4cb4b3d3192ee5380855,

title = "Reply",

author = "Singal, {Amit G.} and Parikh, {Neehar D.} and Murphy, {Caitlin C.}",

note = "Funding Information: Funding Supported by the National Cancer Institute (NCI) R01 CA222900 and grant support from Abbvie. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or Abbvie . The funding agencies had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation of the manuscript. Funding Information: Funding Supported by the National Cancer Institute (NCI) R01 CA222900 and grant support from Abbvie. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or Abbvie. The funding agencies had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation of the manuscript. Conflicts of interest Amit Singal was on speakers bureau for Gilead, Bayer, and Bristol Meyers Squibb. He has served on advisory boards for Gilead, Abbvie, Bayer, Eisai, Bristol Meyers Squibb, Wako Diagnostics, and Exact Sciences. He serves as a consultant to Bayer, Eisai, Exelixis, Roche, Exact Sciences, and Glycotest. He has received research funding from Gilead and Abbvie. Neehar Parikh serves as a consultant to Exelexis and Bristol-Myers Squibb. He has served on advisory boards for Eisai and Bayer. Caitlin Murphy has no relevant conflicts of interest. Funding Information: Conflicts of interest Amit Singal was on speakers bureau for Gilead, Bayer, and Bristol Meyers Squibb. He has served on advisory boards for Gilead, Abbvie, Bayer, Eisai, Bristol Meyers Squibb, Wako Diagnostics, and Exact Sciences. He serves as a consultant to Bayer, Eisai, Exelixis, Roche, Exact Sciences, and Glycotest. He has received research funding from Gilead and Abbvie. Neehar Parikh serves as a consultant to Exelexis and Bristol-Myers Squibb. He has served on advisory boards for Eisai and Bayer. Caitlin Murphy has no relevant conflicts of interest. ",

year = "2020",

month = may,

doi = "10.1053/j.gastro.2020.02.024",

language = "English (US)",

volume = "158",

pages = "1844",

journal = "Gastroenterology",

issn = "0016-5085",

publisher = "W.B. Saunders Ltd",

number = "6",

}

TY - JOUR

T1 - Reply

AU - Singal, Amit G.

AU - Parikh, Neehar D.

AU - Murphy, Caitlin C.

N1 - Funding Information: Funding Supported by the National Cancer Institute (NCI) R01 CA222900 and grant support from Abbvie. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or Abbvie . The funding agencies had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation of the manuscript. Funding Information: Funding Supported by the National Cancer Institute (NCI) R01 CA222900 and grant support from Abbvie. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or Abbvie. The funding agencies had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation of the manuscript. Conflicts of interest Amit Singal was on speakers bureau for Gilead, Bayer, and Bristol Meyers Squibb. He has served on advisory boards for Gilead, Abbvie, Bayer, Eisai, Bristol Meyers Squibb, Wako Diagnostics, and Exact Sciences. He serves as a consultant to Bayer, Eisai, Exelixis, Roche, Exact Sciences, and Glycotest. He has received research funding from Gilead and Abbvie. Neehar Parikh serves as a consultant to Exelexis and Bristol-Myers Squibb. He has served on advisory boards for Eisai and Bayer. Caitlin Murphy has no relevant conflicts of interest. Funding Information: Conflicts of interest Amit Singal was on speakers bureau for Gilead, Bayer, and Bristol Meyers Squibb. He has served on advisory boards for Gilead, Abbvie, Bayer, Eisai, Bristol Meyers Squibb, Wako Diagnostics, and Exact Sciences. He serves as a consultant to Bayer, Eisai, Exelixis, Roche, Exact Sciences, and Glycotest. He has received research funding from Gilead and Abbvie. Neehar Parikh serves as a consultant to Exelexis and Bristol-Myers Squibb. He has served on advisory boards for Eisai and Bayer. Caitlin Murphy has no relevant conflicts of interest.

PY - 2020/5

Y1 - 2020/5

UR - http://www.scopus.com/inward/record.url?scp=85083649242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85083649242&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2020.02.024

DO - 10.1053/j.gastro.2020.02.024

M3 - Letter

C2 - 32084426

AN - SCOPUS:85083649242

VL - 158

SP - 1844

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 6

ER -

Reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this